Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting ...Middle East

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that preclinical data from its lead program, NST-628, will be featured in an oral...

Hence then, the article about nested therapeutics to present preclinical data for nst 628 a novel pan raf mek molecular glue in the new drugs on the horizon series at 2024 aacr annual meeting was published today ( Thursday 28/03/2024 - 02:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting )

Also on site :

• Union boss ‘held up Communist flag alongside people singing pro-Russia chants in occupied Ukraine’
• Large house fire near Buckeye Lake kills one, critically injures second victim
• 'Sister Wives' Meri Brown Opens Up About Family Finances After Consenting to ‘Never Talk’ About Kody Deal